HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kim Kraynyak Selected Research

Immunotherapy

1/2021Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kim Kraynyak Research Topics

Disease

1Squamous Intraepithelial Lesions
01/2021
1HIV Infections (HIV Infection)
03/2015

Drug/Important Bio-Agent (IBA)

1VGX-3100IBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021

Therapy/Procedure

1Immunotherapy
01/2021
1Therapeutics
03/2015